Medical Innovation Bill [HL]

AmendmentS
to be moved
in committee

Clause 1

BARONESS MASHAM OF ILTON

 

Page 1, leave out line 14 and insert—

“( )   providing the patient with a detailed explanation of the aims,
processes and risks associated with the proposed treatment;

( )   obtaining informed consent with reference to all relevant legislation
and professional guidance;

( )   providing the patient with a detailed asssessment of how the
proposed treatment may affect their condition;

( )   providing the patient with information about any factors that may
limit or discontinue their access to the proposed treatment; and”

 

Page 1, line 18, at end insert—

“( )     The Secretary of State may issue additional guidance about the necessary
steps for obtaining informed consent under subsection (3).”

LORD HUNT OF KINGS HEATH

BARONESS WHEELER

 

Page 2, line 7, at end insert—

“( )     The Secretary of State must exercise the functions of the Secretary of State
in relation to the health service with a view to supporting responsible
innovation in medical treatment, as encouraged by this section.

( )     The following bodies must exercise their functions in relation to the health
service with a view to supporting responsible innovation in medical
treatment, as encouraged by this section—

(a)   NHS Commmissioning Board;

(b)   Clinical Commissioning Groups;

(c)   NHS Trusts;

(d)   NHS Foundation Trusts;

(e)   Care Quality Commission;

(f)   Monitor;

(g)   NHS Trust Development Authority;

(h)   Health Education England; and

(i)   Health Research Authority.”

After Clause 1

BARONESS MASHAM OF ILTON

 

Insert the following new Clause—

“Availability of treatments

The Secretary of State must—

(a)   periodically publish an assessment of geographical variances in the
availability of innovative treatments; and

(b)   set out steps to promote uniform access to innovative treatments.”

Clause 2

LORD SAATCHI

 

Page 2, line 10, leave out “it” and insert “this Act”

Prepared 21st October 2014